Cargando…
Effect of chemotherapy and aromatase inhibitors in the adjuvant treatment of breast cancer on glucose and insulin metabolism—A systematic review
INTRODUCTION: Breast cancer (BC) is the most common cancer among women worldwide. With increasing survival rates, focus has expanded to long‐term adverse effects of adjuvant chemotherapy and/or aromatase inhibitors. Weight gain during chemotherapy has been well documented, but the underlying mechani...
Autores principales: | Buch, Kristian, Gunmalm, Victoria, Andersson, Michael, Schwarz, Peter, Brøns, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346263/ https://www.ncbi.nlm.nih.gov/pubmed/30561133 http://dx.doi.org/10.1002/cam4.1911 |
Ejemplares similares
-
Aromatase in human liver and its diseases
por: Hata, Shuko, et al.
Publicado: (2013) -
FRAX Calculated without BMD Resulting in a Higher Fracture Risk Than That Calculated with BMD in Women with Early Breast Cancer
por: Prawiradilaga, Rizky Suganda, et al.
Publicado: (2018) -
Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients
por: Dackus, Gwen M H E, et al.
Publicado: (2021) -
Safety of aromatase inhibitors in the adjuvant setting
por: Perez, Edith A.
Publicado: (2007) -
Safety of aromatase inhibitors in the adjuvant setting
por: Perez, Edith A.
Publicado: (2007)